Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 2 | 2017 | 1536 | 0.570 |
Why?
|
| Ovarian Reserve | 1 | 2016 | 2 | 0.560 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 60 | 0.550 |
Why?
|
| Infertility | 1 | 2016 | 26 | 0.550 |
Why?
|
| BRCA1 Protein | 1 | 2016 | 30 | 0.550 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 99 | 0.540 |
Why?
|
| Receptor, ErbB-2 | 1 | 2017 | 129 | 0.540 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 267 | 0.480 |
Why?
|
| Isometric Contraction | 1 | 2009 | 33 | 0.340 |
Why?
|
| Ankle Joint | 1 | 2009 | 57 | 0.330 |
Why?
|
| Postural Balance | 1 | 2009 | 93 | 0.330 |
Why?
|
| Electric Stimulation | 1 | 2009 | 218 | 0.330 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 396 | 0.270 |
Why?
|
| Adaptive Clinical Trials as Topic | 1 | 2017 | 2 | 0.140 |
Why?
|
| Epidemiologic Research Design | 1 | 2017 | 5 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 28 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 36 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2017 | 159 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 41 | 0.120 |
Why?
|
| Mutation | 2 | 2016 | 1213 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 931 | 0.110 |
Why?
|
| Young Adult | 2 | 2016 | 5717 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 468 | 0.100 |
Why?
|
| Adolescent | 2 | 2016 | 8912 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2017 | 2007 | 0.090 |
Why?
|
| Female | 5 | 2017 | 38074 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1070 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 208 | 0.080 |
Why?
|
| Middle Aged | 3 | 2016 | 21147 | 0.070 |
Why?
|
| Adult | 3 | 2016 | 21403 | 0.070 |
Why?
|
| Humans | 4 | 2017 | 68618 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2003 | 470 | 0.050 |
Why?
|
| Aging | 1 | 2003 | 911 | 0.040 |
Why?
|
| Ketones | 1 | 2015 | 24 | 0.030 |
Why?
|
| Carboplatin | 1 | 2015 | 59 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2015 | 35 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2015 | 47 | 0.030 |
Why?
|
| Furans | 1 | 2015 | 27 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 111 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 104 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 536 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 880 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 800 | 0.030 |
Why?
|
| Male | 2 | 2009 | 37321 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2003 | 29 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2003 | 104 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2003 | 150 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2003 | 49 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 7029 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 303 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 245 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 396 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 220 | 0.010 |
Why?
|
| Motor Activity | 1 | 2003 | 621 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14862 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 2083 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 2334 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 5300 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 20881 | 0.000 |
Why?
|